Session Type
Meeting
Search Results for Liver Transplant
Abstract Number: 353
Hospital Medicine 2020, Virtual Competition
Background: Successful hospitalist co-management programs address provider knowledge base as well as ongoing faculty skill development and education (1). With a growing liver transplant program, our institution has seen increased patient volume on the hospitalist liver service. Hospitalists and hepatologists co-manage this expanding population of high acuity patients with complex pathologies. In the past year, […]
Abstract Number: 515
Hospital Medicine 2020, Virtual Competition
Case Presentation: The patient is a 58-year-old male with a past medical history of end-stage liver cirrhosis status post-liver transplantation in 1991 who was on tacrolimus (TAC) 1 mg twice a day. He was admitted for altered mental status, fever and respiratory distress. He was found to have bilateral pneumonia treated as community-acquired pneumonia. The […]
Abstract Number: 625
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 53-year-old woman with a history of metabolic syndrome and necrotizing pancreatitis presented with new onset ascites. Her story began nine months earlier, when she developed abdominal pain. CT at that time revealed pancreatitis and cholelithiasis without biliary dilation. Lab values were notable for: lipase 55000, total bilirubin (TBIL) 5.3, AST 660, ALT […]
Abstract Number: 867
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 65-year-old male presented to the emergency department with a 5-week history of epigastric pain, nausea, constipation and weight loss. Past medical history was significant for combined liver and kidney transplant 3 years prior due to hepatitis C cirrhosis and hepatorenal syndrome. Chronic immunosuppression consisted of mycophenolate mofetil, tacrolimus and prednisone. Laboratory studies […]
Abstract Number: 882
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 63 year-old woman with a history of liver transplant presented to a rural hospital for evaluation of rigors, nausea and vomiting. Her post-transplant course had been complicated by HCV recurrence treated successfully with interferon and ribavirin; cirrhosis, and refractory gastric variceal bleeding for which she received a transjugular intrahepatic portosystemic shunt (TIPS) […]
Abstract Number: 1210
Hospital Medicine 2020, Virtual Competition
Background: Hepatitis C virus (HCV) is a leading cause for liver cirrhosis and one of the commonest indications for liver transplantation. The introduction of direct acting antiviral (DAA) medications have revolutionized the treatment for HCV. Prior to 2014, the treatment for HCV consisted of interferon and ribavirin which yielded a sustained virologic response (SVR) of […]